| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EQRx, Inc. | Director | Common Stock | 0 | $2.21 | 09 Nov 2023 | Direct | |
| EQRx, Inc. | Director | Stock Option (Right to Buy) | 0 | 09 Nov 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924323020292-abernethy-amy-2023-11-09 | EQRx, Inc. | 09 Nov 2023 | 2 | $0 | 4 | Director | 09 Nov 2023, 16:06 |
| /report/000110465923024299-abernethy-amy-2022-09-30-restatement | EQRx, Inc. | 30 Sep 2022 | 1 | $0 | 4/A | Director | 22 Feb 2023, 15:07 |
| /report/000110465923024293-abernethy-amy-2022-02-25-restatement | EQRx, Inc. | 25 Feb 2022 | 1 | $0 | 4/A | Director | 22 Feb 2023, 15:05 |
| /report/000089924321049125-abernethy-amy-2021-12-17 | EQRx, Inc. | 17 Dec 2021 | 4 | $0 | 4 | Director | 21 Dec 2021, 05:30 |
| /report/000121390021040107-abernethy-amy-2021-08-02 | CM Life Sciences III Inc. | 02 Aug 2021 | 0 | $0 | 3 | Director | 03 Aug 2021, 16:24 |